SPP1 and squamous cell carcinoma: To investigate if S100A4 stimulates expression of ephrin-A1 and osteopontin in NSCLC, two adenocarcinoma and two squamous cell carcinoma cell lines were treated with 2 and 10 μg/ml recombinant S100A4 for 6 and 24 hours.